US equities |
MU $1,088.00 ▲+0.00% SNDK $1,692.42 ▲+0.00% NVDA $237.47 ▲+0.00% INTC $113.12 ▲+0.00% AMD $645.86 ▲+0.00% SPCX $167.60 ▲+0.00% PLTR $194.12 ▲+0.00% NBIS $237.15 ▲+0.00%
FinancialContent

Nasus Pharma Ltd. Ordinary Shares (NY:NSRX)

3.775 UNCHANGED
Delayed Quote Updated: 8:00 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nasus Pharma Ltd. Ordinary Shares

News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
These stocks are moving in today's session ↗
Via Chartmill
News headline image
RedChip's Biotech Virtual Investor Conference Replays Now Available
Via ACCESS Newswire
News headline image
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
Via ACCESS Newswire
On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Could Nasal Powders Be the Next Revolution in Emergency Medicine?
Via AB Newswire
Topics Initial Public Offering
The Underdog Disruptor: Why Nasus Pharma Could Be the Sleeper Stock Ready to Shake Up Billion-Dollar Markets
Via AB Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
Nasus Pharma Receives $22 Price Target and Buy Rating From Laidlaw & Company
Via AB Newswire